BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1730257)

  • 1. Pre-B lymphocyte-specific transcriptional control of the mouse VpreB gene.
    Okabe T; Bauer SR; Kudo A
    Eur J Immunol; 1992 Jan; 22(1):31-6. PubMed ID: 1730257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The murine VpreB1 and VpreB2 genes both encode a protein of the surrogate light chain and are co-expressed during B cell development.
    Dul JL; Argon Y; Winkler T; ten Boekel E; Melchers F; Mårtensson IL
    Eur J Immunol; 1996 Apr; 26(4):906-13. PubMed ID: 8625987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 14.1 surrogate light chain promoter has lineage- and stage-restricted activity.
    Donohoe ME; Blomberg BB
    J Immunol; 1997 Feb; 158(4):1681-91. PubMed ID: 9029104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pre-B- and B cell-specific DNA-binding protein, EBB-1, which binds to the promoter of the VpreB1 gene.
    Okabe T; Watanabe T; Kudo A
    Eur J Immunol; 1992 Jan; 22(1):37-43. PubMed ID: 1730258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and localization of a developmental stage-specific promoter activity from the murine lambda 5 gene.
    Yang J; Glozak MA; Blomberg BB
    J Immunol; 1995 Sep; 155(5):2498-514. PubMed ID: 7650380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping and functional analysis of regulatory sequences in the mouse lambda5-VpreB1 domain.
    Minaee S; Farmer D; Georgiou A; Sabbattini P; Webster Z; Chow CM; Dillon N
    Mol Immunol; 2005 Jul; 42(11):1283-92. PubMed ID: 15950724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A truncated heavy chain protein relieves the requirement for surrogate light chains in early B cell development.
    Shaffer AL; Schlissel MS
    J Immunol; 1997 Aug; 159(3):1265-75. PubMed ID: 9233622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The VpreB1 enhancer drives developmental stage-specific gene expression in vivo.
    Licence S; Persson C; Mundt C; Mårtensson IL
    Eur J Immunol; 2003 Apr; 33(4):1117-26. PubMed ID: 12672078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Only VpreB1, but not VpreB2, is expressed at levels which allow normal development of B cells.
    Mundt C; Licence S; Maxwell G; Melchers F; Mårtensson IL
    Int Immunol; 2006 Jan; 18(1):163-72. PubMed ID: 16361315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of surrogate light chain in common variable immunodeficiency.
    Yano M; Kondo N; Kato Y; Shinoda S; Inoue R; Orii T
    Exp Clin Immunogenet; 1995; 12(1):1-9. PubMed ID: 7710759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surrogate-light-chain silencing is not critical for the limitation of pre-B cell expansion but is for the termination of constitutive signaling.
    van Loo PF; Dingjan GM; Maas A; Hendriks RW
    Immunity; 2007 Sep; 27(3):468-80. PubMed ID: 17869135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lambda5-VpreB1 locus--a model system for studying gene regulation during early B cell development.
    Sabbattini P; Dillon N
    Semin Immunol; 2005 Apr; 17(2):121-7. PubMed ID: 15737573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mouse BP-1 gene: structure, chromosomal localization, and regulation of expression by type I interferons and interleukin-7.
    Wang J; Walker H; Lin Q; Jenkins N; Copeland NG; Watanabe T; Burrows PD; Cooper MD
    Genomics; 1996 Apr; 33(2):167-76. PubMed ID: 8660964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell development in mice with a defective lambda 5 gene.
    Rolink A; Karasuyama H; Grawunder U; Haasner D; Kudo A; Melchers F
    Eur J Immunol; 1993 Jun; 23(6):1284-8. PubMed ID: 7684685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.
    Kitamura D; Roes J; Kühn R; Rajewsky K
    Nature; 1991 Apr; 350(6317):423-6. PubMed ID: 1901381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surrogate light chain production during B cell differentiation: differential intracellular versus cell surface expression.
    Wang YH; Nomura J; Faye-Petersen OM; Cooper MD
    J Immunol; 1998 Aug; 161(3):1132-9. PubMed ID: 9686571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic analysis of the interactions of recombinant human VpreB and Ig V domains.
    Hirabayashi Y; Lecerf JM; Dong Z; Stollar BD
    J Immunol; 1995 Aug; 155(3):1218-28. PubMed ID: 7636190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell surface expression of surrogate light chain (psi L) in the absence of mu on human pro-B cell lines and normal pro-B cells.
    Meffre E; Fougereau M; Argenson JN; Aubaniac JM; Schiff C
    Eur J Immunol; 1996 Sep; 26(9):2172-80. PubMed ID: 8814264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repertoire selection by pre-B-cell receptors and B-cell receptors, and genetic control of B-cell development from immature to mature B cells.
    Melchers F; ten Boekel E; Seidl T; Kong XC; Yamagami T; Onishi K; Shimizu T; Rolink AG; Andersson J
    Immunol Rev; 2000 Jun; 175():33-46. PubMed ID: 10933589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The surrogate light chain in B-cell development.
    Melchers F; Karasuyama H; Haasner D; Bauer S; Kudo A; Sakaguchi N; Jameson B; Rolink A
    Immunol Today; 1993 Feb; 14(2):60-8. PubMed ID: 8166770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.